| 1 |
Exploring the Metastatic Castration-Sensitive Prostate Cancer Market Landscape |
Visit Post |
| 2 |
Accutar's Phase I clinical trial for AC0176; Bio-Thera's cancer drug, BAT6005; Nykode's Covid-19 vaccine trial; Heat Biologics acquires Elusys |
Visit Post |
| 3 |
Market Heats Up as Managing Benign Prostatic Hyperplasia Through Devices Gains Traction |
Visit Post |
| 4 |
Ewing Sarcoma: Key Companies and Emerging Therapies in the Landscape |
Visit Post |
| 5 |
The Obesity Pandemic: What can we do about it? |
Visit Post |
| 6 |
A Globally Rising Burden of Sexually Transmitted Diseases (STDs) |
Visit Post |
| 7 |
Prostate Cancer Market Experiences an Influx of the Pharma Players Veering the Market Ahead |
Visit Post |
| 8 |
Moderna's COVID-19 Vaccine; Quidel's Lyra gets EUA from FDA; Neurotrope and Metuchen Pharma Announced Merger Agreement; FDA Approval to Rucaparib; |
Visit Post |
| 9 |
Novartis signs; Sosei passes; Amgen remunerates; J&J remunerates for RSV drug |
Visit Post |
| 10 |
CRISPR to cure sickle cell; FDA rejected; Stem cells use; Celgene spinoff |
Visit Post |
| 11 |
Remicade’s launch; Endo cuts jobs; Analysts downgrade Pfizer; Corning $500M glass project |
Visit Post |
